Innovent Biologics to Join Hong Kong’s Equity Benchmark Index

Hang Seng Indexes Co. added biopharmaceutical company Innovent Biologics Inc. to its Hong Kong stock benchmark, the index compiler said following its quarterly review.

By Sangmi Cha · Bloomberg Markets

Hang Seng Indexes Co. added biopharmaceutical company Innovent Biologics Inc. to its Hong Kong stock benchmark, the index compiler said following its quarterly review.